早期停用质子泵抑制剂对肾衰竭的因果效应
该研究采用目标试验模拟方法,在非透析慢性肾脏病患者中比较质子泵抑制剂(PPI)与H2受体拮抗剂使用对肾衰竭风险的影响,并评估起始PPI后90天内停药的效果。结果显示PPI起始与肾衰竭风险升高相关,而早期停药与较低肾衰竭风险相关。
要点
- PPI起始与新发肾衰竭风险升高相关(HR 1.39)。
- 起始PPI后90天内停药与肾衰竭风险降低相关(HR 0.85)。
- 临床应避免无明确指征的长期PPI使用。
核心结论
- 起始PPI与肾衰竭风险升高相关,而起始后90天内停用PPI与较低肾衰竭风险相关。
研究设计与样本
- 基于日本大阪肾脏病研究联盟的多中心回顾性队列,在非透析CKD患者中模拟两项目标试验。
- 第一项采用活性对照新用户设计比较PPI与H2受体拮抗剂,第二项采用克隆-删失-加权法评估90天内停药效应。
- 共纳入3512例PPI新用户(76.1%)和1102例H2受体拮抗剂新用户(23.9%)。
主要发现
- 起始治疗时平均年龄71岁,平均eGFR为30 ml/min per 1.73 m2。
- 中位随访2.1年期间,654例(14.2%)进展为肾衰竭需替代治疗。
- PPI起始与肾衰竭需替代治疗风险升高显著相关(HR 1.39;95%CI 1.13-1.72)。
- 4187例起始PPI的患者中,1254例(30.0%)在90天内停药。
- 90天内停药与继续使用相比,肾衰竭需替代治疗风险显著降低(HR 0.85;95%CI 0.72-0.97)。
临床怎么用
- 对起始PPI的CKD患者,应评估用药指征并在90天内考虑停用无明确指征的PPI以降低肾衰竭风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Proton pump inhibitors (PPIs) are associated with adverse kidney outcomes. In clinical practice, however, long-term PPI use without a clear indication is common. It remains unclear whether discontinuing PPIs reduces the risk of kidney failure in patients who initiate PPIs. Using a target trial emulation approach, we estimated the causal effects of initiation and discontinuation of PPIs on the risk of kidney failure. METHODS: Using data from the Osaka Consortium for Kidney Disease Research, a retrospective multicenter cohort in Japan, we emulated 2 target trials in patients with nondialyzed chronic kidney disease (CKD). First, we compared the risk of kidney failure with replacement therapy (KFRT) between PPI use and histamine2 receptor antagonist (H2 blocker) use, using an active comparator new user design. Second, the estimated effect of PPI discontinuation within 90 days after initiation on KFRT was evaluated using a clone-censor-weighting approach. RESULTS: We identified 3512 PPI new users (76.1%) and 1102 H2 blocker new users (23.9%). At treatment initiation, the mean age and estimated glomerular filtration rate (eGFR) were 71 years and 30 ml/min per 1.73 m2, respectively. Over a median follow-up of 2.1 years, 654 (14.2%) progressed to KFRT. PPI initiation was significantly associated with a higher hazard of KFRT (hazard ratio [HR]: 1.39; 95% confidence interval [CI]: 1.13-1.72). Of 4187 patients who initiated PPIs, 1254 (30.0%) discontinued PPIs within 90 days. Discontinuation was significantly associated with a lower hazard of KFRT (HR: 0.85; 95% CI: 0.72-0.97) than continuation. CONCLUSION: Discontinuing PPIs within 90 days after initiation was associated with better kidney outcome.
引用
- Kawano Y, Oka T, Sakaguchi Y, et al. Causal Effects of Early Discontinuation of Proton Pump Inhibitors on Kidney Failure. Kidney Int Rep. 2026. PMID: 42620965. doi:10.1016/j.ekir.2026.106709
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。